These results suggest that CD24+LCN2+ LPCs might regulate the TPPP3+COL10A1+ proinflammatory MP-2 subpopulation involved in the profibrotic progression process of MASLD. The gene discussed is LCN2; the disease is metabolic dysfunction-associated steatotic liver disease.